BrightGene Investor
%20.jpg)
BrightGene is a biopharma company.
Funding Status:
IPO
Headquarters:
China
Founded Date:
2001-01-01
Last Funding Type:
Venture - Series Unknown
Total Funding:
550000000 CNY
Estimated Revenue:
$10M to $50M
Industry:
Biotechnology, Health Care, Science and Engineering
Investors Number:
4
Last Funding Date:
2019-01-07